Navigation Links
Eurofins MWG Operon and Queen Mary, University Of London commence genome sequencing analysis of Ash
Date:3/14/2013

Ebersberg, Germany, March 14, 2013 - Eurofins MWG Operon and School of Biological and Chemical Sciences, Queen Mary, University of London, have recently signed a cooperation agreement on the genome sequencing analysis of Ash (Fraxinus excelsior). The major aim of this project is to increase our understanding of the wide spreading fungal tree disease ash dieback (Hymenoscyphus pseudoalbidus), which is widespread in northern Europe and has already been found at more than 300 sites across the UK.

Project leader, Dr. Richard Buggs from Queen Mary's School of Biological and Chemical Sciences: "Sequencing the ash genome is a foundational step towards discovering the genetic basis of resistance to ash dieback the future of ash trees in Britain may depend on this". His research is funded by an urgency grant from the Natural Environment Research Council.

Sequencing of the approximately 900 Mb plant genome will be performed applying the latest hybrid de novo sequencing strategy, recently proven to deliver excellent scaffolding and assembly results.This new golden standard in de novo sequencing employs a combination of Roche/454 FLX++ long read technology (software version 2.8 with read lengths up to 1,100 bp) and Illumina HiSeq 2000/2500 high throughput sequencing with several ultra-accurate long jumping distance libraries (LJD of 3kb, 8kb, 20kb and 40kb), supplemented by sequencing of Illumina shotgun libraries with different fragment sizes.

The DNA samples provided by Dr. Richard Buggs, Queen Mary University of London, from tree material supplied by Earth Trust, Oxfordshire, have successfully passed the first QC steps in lab, while the Eurofins MWG Operon NGS sequencing service pipeline is already planning the first sequencing runs starting with GS FLX++.

"We take specific care that our technical and operational pipeline meets the best quality standards, fast turnaround times and the high service level we want to provide to our customers", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "Our specific library know-how fits seamlessly to this challenging and important genome sequencing project and we are confident that we will deliver excellent results."


'/>"/>

Contact: Dr. Alex Goodwin
alexgoodwin@eurofins.com
44-771-736-6379
Eurofins MWG Operon
Source:Eurekalert

Related biology news :

1. Eurofins MWG Operon reinforces NGS capability with Illumina HiSeq 2500 and Illumina MiSeq
2. Rice, MD Anderson scientists probe mystery of operon evolution
3. Researchers id queens, mysterious disease syndrome as key factors in bee colony deaths
4. Queens Diamond Jubilee Medal for obesity research expert
5. What it is to be a queen bee?
6. Queens University Belfast makes significant cancer breakthrough
7. Queens researcher finds situation dire for threatened rhino species
8. Enhanced royal jelly produces jumbo queen bee larvae
9. Queens is UK leader for female scientists and engineers
10. Life expectancy may affect when you get married, divorced, have kids: Queens University study
11. Queens scientists seek vaccine for Pseudomonas infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/12/2017)... 2017  Trovagene, Inc. (NASDAQ: TROV ), ... announced that it has signed agreements with seven strategic ... Middle East for commercialization of ... first wave of international distribution agreements for Trovagene,s CLIA ... The initial partners will introduce Trovagene,s liquid ...
(Date:1/6/2017)... 2017  Privately-held CalciMedica, Inc., announced that it ... of a novel calcium release-activated calcium (CRAC) channel ... Acute pancreatitis, sudden painful inflammation of ... can be very serious.  In severe cases it can ... hospital stays, time in the ICU and substantial ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider of ... of Onitor Track, an innovative biometric data-driven program designed ... this month at the 2017 Consumer Electronics Show (CES) ... In the U.S., the World Health Organization (WHO), ... two-thirds of adults who are overweight or obese. WHO ...
Breaking Biology News(10 mins):
(Date:1/23/2017)... N.J. , Jan. 23, 2017   Enteris ... feasibility study agreement with Sanofi to leverage ... delivery platform, Peptelligenceā„¢, to develop an oral formulation of ... Joel Tune , Chief Executive Officer and Executive ... is further validation of the tremendous value our Peptelligence ...
(Date:1/23/2017)... 2017  Alkahest Inc. ("Alkahest"), a biotechnology company ... and other age-related conditions, announced today that Sam Jackson, ... Medical Officer. In this role, Dr. Jackson will ... Alkahest and serve on the Executive Leadership Team.  ... Executive Director at Dynavax, where he led the Drug ...
(Date:1/21/2017)... ... ... Nipro Corporation (Osaka, Japan) and Transonic Systems Inc. (New York, USA) announced the ... sales rights for all non-OEM Transonic products in Japan. As partners for more than ... - Transonic JV is a natural next step to advance best practices and further ...
(Date:1/21/2017)... , Jan. 20, 2017 Aratana Therapeutics, ... company focused on the licensing, development and commercialization of ... Pharm,s Best Company in North America ... the award based on the FDA approval ... (grapiprant tablets), ENTYCE Ā® (capromorelin oral solution) and ...
Breaking Biology Technology: